Finely something we agree on yes in general MD's and the top management team's of many companies often seem to be over paid.
Mesoblast is not the normal, as such general observation of companies
listed on the ASX simply are useless.
MSB's BOD are leading scientists and if you care to look at what the team have achieved , very successful. In my opinion great value for MSB . As for thire corporate skills, free bonus for holders .
Have you had time to look at the video yet?
Ann: Appendix 4C - quarterly, page-131
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2482 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 27045 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |